# Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation)

> **NCT07706075** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Muhammad Ali Javed** · enrollment: 120 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Atrial Fibrillation With Rapid Ventricular Response

## Interventions

- **DRUG:** Verapamil Hydrochloride
- **DRUG:** Metoprolol tartrate

## Key facts

- **NCT ID:** NCT07706075
- **Lead sponsor:** Muhammad Ali Javed
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01-01
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07706075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07706075, "Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation)". Retrieved via MORVS 2026-10-30 from https://api.morvs.ai/clinical/NCT07706075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*